DrugPatentWatch Database Preview
Details for Patent: 8,137,993
Which drugs does patent 8,137,993 protect, and when does it expire?
Summary for Patent: 8,137,993
Title: | Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof |
Abstract: | The present invention is directed to a method of identifying patients to be treated by dopamine agonist therapy comprising the step of analyzing a plasma or urine sample from said patient for concentrations of norepinephrine (NE), norepinephrine metabolites (NE metabolites), dopamine, dopamine metabolites, serotonin, serotonin metabolites, or fasting triglycerides, wherein one or more of: (a) NE metabolites, (b) NE/NE metabolites: dopamine/dopamine metabolites, (c) NE and serotonin, (d) NE/NE metabolites and serotonin, (e) NE and serotonin metabolites, (f) NE/NE metabolites and serotonin metabolites, or (g) NE is/are greater than about 30% over normal level; or dopamine/dopamine metabolites are less than about 30% below normal; or fasting triglycerides are greater than about 150 mg/dl and/or said patient has hypertension. The present invention is also directed to treating identified patients with dopamine agonist therapy. |
Inventor(s): | Cincotta; Anthony H. (Tiverton, RI) |
Assignee: | VeroScience LLC (Tiverton, RI) |
Application Number: | 13/066,255 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 8,137,993
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | IMPROVEMENTS OF GLYCEMIC CONTROL IN INDIVIDUALS WITH TYPE 2 DIABETES WHO HAVE ONE OR MORE SPECIFIED CARDIOVASCULAR RISK FACTORS | ➤ Try a Free Trial | ||||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
Non-Orange Book US Patents Family Members for Patent 8,137,993
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
Patent No. | Title | Estimated Patent Expiration |
---|---|---|
8,137,994 | Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof | ➤ Try a Free Trial |
7,888,310 | Methods of identifying responders to dopamine agonist therapy | ➤ Try a Free Trial |
8,137,992 | Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof | ➤ Try a Free Trial |
Patent No. | Title | Estimated Patent Expiration |